Anti-inflammatory Agents Market Research Report from 2024 forecast to 2030, by Manufacturers, Regions, Type and Application

The global Anti-inflammatory Agents market size was valued at USD 100940 million in 2023 and is forecast to a readjusted size of USD 132390 million by 2030 with a CAGR of 3.9% during review period.

Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat migraines, headaches, rheumatic arthritis, sprains, and menstrual pain. Furthermore, some anti-inflammatory agents such as celecoxib and ibuprofen are being studied for the prevention and treatment of cancer. In addition, they can provide faster relief as compared to other drugs. They are capable of lowering the levels of prostaglandins and the chemicals responsible for inflammation, thereby reducing pain and swelling. Anti-inflammatory drugs usually target the anti-inflammatory mediators or enzymes. These drugs are often used in combination of other drugs. Inflammation is the most prevalent treatable symptom among many immune and respiratory diseases.

The growth of the global anti-inflammatory agents' market has been driven by factors such as increase in prevalence of autoimmune & respiratory conditions, new drugs in pipeline, and surge in adoption of anti-inflammatory drugs. Furthermore, the demand for anti-inflammatory drugs has been increasing exponentially, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, rise in awareness of anti-inflammatory therapeutics and attractive government initiatives toward the treatment of inflammation with nonsteroidal anti-inflammatory drugs in Asia-Pacific and LAMEA are expected to drive the market growth during the analysis period. However, factors such as side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade) impede the market growth.

This report is a detailed and comprehensive analysis for global Anti-inflammatory Agents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Anti-inflammatory Agents market size and forecasts, in consumption value ($ Million), 2019-2030
Global Anti-inflammatory Agents market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Anti-inflammatory Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Anti-inflammatory Agents market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-inflammatory Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Anti-inflammatory Agents market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

   Thermo Fisher Scientific Inc
   Oracle Corporation
   Revvity, Inc
   Clario
   Illumina, Inc
   Qiagen NV
   Agilent Technologies, Inc
   IBM Corporation
   Genedata AG
   DNAnexus, Inc

   Software
   Services

   Pharmaceutical and Biotechnology Companies
   Contract Research and Development Organizations
   Others

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the Anti-inflammatory Agents Market in 2025?

The growing prevalence of chronic diseases, such as arthritis, cardiovascular disorders, and autoimmune conditions, continues to drive demand for anti-inflammatory agents. Advancements in drug formulations and targeted therapies are enhancing the efficacy and safety profiles of these agents. Additionally, the increasing awareness and early diagnosis of inflammatory conditions are likely to boost market growth.

What are the weaknesses of the Anti-inflammatory Agents Market in 2025?

High treatment costs and the risk of side effects associated with long-term use of anti-inflammatory agents, such as gastrointestinal issues or cardiovascular risks, can limit market growth. Furthermore, the over-reliance on pharmaceutical treatments may deter patients from exploring alternative therapies, leading to slower adoption of new, potentially safer options.

What are the opportunities for the Anti-inflammatory Agents Market in 2025?

Emerging markets in Asia and Latin America present significant growth opportunities as healthcare access improves. Additionally, the rise of personalized medicine and the development of biologic therapies offer the potential for more effective and safer treatment options. Ongoing research into the anti-inflammatory properties of certain biologics and gene therapies is expected to open new frontiers for the market.

What are the threats to the Anti-inflammatory Agents Market in 2025?

The market may face increased competition from biosimilars, which are expected to lower the prices of existing biologic treatments, putting pressure on profits. Regulatory hurdles and the slow approval process for new drugs could delay market entry. Furthermore, rising concerns over the long-term environmental impact of pharmaceutical waste might lead to stricter regulations on the production and disposal of these agents.

What are the political factors affecting the Anti-inflammatory Agents Market in 2025?

Government healthcare policies, particularly in regions like the U.S. and Europe, can influence market growth through drug pricing regulations and reimbursement schemes. Political instability in emerging markets may also affect drug distribution and market expansion, while government support for pharmaceutical innovation can foster research into more effective anti-inflammatory treatments.

What are the economic factors influencing the Anti-inflammatory Agents Market in 2025?

Economic growth in developing nations, along with rising healthcare expenditure, will drive demand for anti-inflammatory agents. However, economic downturns or recessions could result in budget cuts for healthcare systems, limiting access to newer, costlier drugs. Price sensitivity in these regions could push demand toward generic alternatives.

What are the social factors shaping the Anti-inflammatory Agents Market in 2025?

An aging global population, particularly in developed countries, will increase the incidence of inflammatory-related conditions, boosting market demand. Furthermore, the growing emphasis on health and wellness will encourage individuals to seek timely treatments for inflammatory diseases. However, cultural preferences for traditional or alternative medicine could limit the adoption of pharmaceutical treatments in certain regions.

What are the technological factors influencing the Anti-inflammatory Agents Market in 2025?

Advances in biotechnology and personalized medicine are likely to revolutionize the development of anti-inflammatory drugs. Innovations such as biologics and gene therapies will offer more targeted treatments with fewer side effects. Furthermore, digital health tools and telemedicine may enhance patient access to anti-inflammatory therapies, particularly in underserved areas.

What are the environmental factors impacting the Anti-inflammatory Agents Market in 2025?

Environmental concerns surrounding pharmaceutical waste and its impact on ecosystems could lead to stricter regulations on drug production and disposal. Sustainable manufacturing practices and eco-friendly packaging may become important differentiators for pharmaceutical companies in the market. Additionally, climate change and its impact on disease patterns could influence the demand for anti-inflammatory drugs.

What are the legal factors affecting the Anti-inflammatory Agents Market in 2025?

Patent laws and intellectual property rights will play a critical role in the market, as pharmaceutical companies seek to protect their innovations. Legal frameworks surrounding drug approval processes, clinical trial regulations, and labeling requirements can affect the speed at which new treatments enter the market. The increasing global emphasis on data privacy and regulatory compliance will also affect how companies conduct research and manage patient data.

Who are the suppliers in the Anti-inflammatory Agents Market in 2025?

The suppliers in this market include pharmaceutical companies that manufacture raw materials, active pharmaceutical ingredients (APIs), and biologics used in anti-inflammatory treatments. Additionally, contract manufacturers, research institutions, and biotechnology firms contribute to the supply of advanced therapies and drug formulations.

What are the inputs in the Anti-inflammatory Agents Market in 2025?

Inputs include the active pharmaceutical ingredients (APIs), raw materials for drug production, scientific research and clinical trial data, regulatory approvals, and technology for drug delivery systems. These inputs are crucial for developing and producing anti-inflammatory agents that meet market demand.

What are the processes involved in the Anti-inflammatory Agents Market in 2025?

Processes involve extensive research and development (R&D), including pre-clinical studies, clinical trials, regulatory approval, manufacturing, and distribution. Post-market surveillance and ongoing improvements based on patient feedback and clinical results are also important processes to ensure drug efficacy and safety.

Who are the customers in the Anti-inflammatory Agents Market in 2025?

Customers include healthcare providers such as hospitals, clinics, and doctors who prescribe anti-inflammatory drugs to treat chronic and acute inflammatory conditions. Additionally, patients who suffer from diseases like arthritis, cardiovascular conditions, and autoimmune disorders represent a significant portion of the customer base.

What are the outputs in the Anti-inflammatory Agents Market in 2025?

Outputs consist of various anti-inflammatory drug formulations, including over-the-counter medications, biologics, biosimilars, and prescription drugs. These outputs aim to alleviate inflammation, reduce pain, and improve the quality of life for individuals suffering from inflammatory diseases.

What is the threat of new entrants in the Anti-inflammatory Agents Market in 2025?

The threat of new entrants is moderate due to high barriers to entry such as regulatory requirements, research and development costs, and the need for significant capital investment. Established pharmaceutical companies with well-recognized brands and extensive distribution networks also pose challenges for new players.

What is the bargaining power of suppliers in the Anti-inflammatory Agents Market in 2025?

The bargaining power of suppliers is relatively moderate. While there are many suppliers of raw materials and active pharmaceutical ingredients, the dependence on specialized ingredients for biologic drugs and the need for high-quality manufacturing standards give certain suppliers more leverage in the market.

What is the bargaining power of buyers in the Anti-inflammatory Agents Market in 2025?

The bargaining power of buyers is moderate to high, particularly for large healthcare institutions and insurance providers who can negotiate pricing and reimbursement terms. However, for individual consumers, especially in regions with limited access to generics or lower-cost alternatives, bargaining power is lower.

What is the threat of substitute products in the Anti-inflammatory Agents Market in 2025?

The threat of substitutes is moderate. While there are alternative treatments like corticosteroids and natural remedies, these often come with side effects or lower efficacy. New, innovative biologics and gene therapies, however, could provide stronger alternatives to traditional anti-inflammatory agents.

What is the intensity of competitive rivalry in the Anti-inflammatory Agents Market in 2025?

The intensity of competitive rivalry is high, driven by the presence of numerous well-established pharmaceutical companies competing in both the generic and branded segments. The market is also seeing increased competition from biosimilars and the emergence of new, more effective therapies, further intensifying the competition.

What are the key raw materials and inputs required for the Anti-inflammatory Agents Market in 2025?

The key raw materials for the production of anti-inflammatory agents include active pharmaceutical ingredients (APIs) such as corticosteroids, biologics, and other specialized compounds. Additionally, excipients, chemical reagents, packaging materials, and high-quality manufacturing equipment are essential for producing the final product.

What are the main suppliers and their role in the Anti-inflammatory Agents Market in 2025?

Suppliers in the upstream segment include pharmaceutical manufacturers, biotech companies, and raw material suppliers who provide APIs, biologic components, and specialized technology for drug production. Contract manufacturers also play a critical role in scaling up production and meeting demand for anti-inflammatory agents.

What is the regulatory environment influencing upstream activities in the Anti-inflammatory Agents Market in 2025?

The regulatory environment for upstream activities is highly stringent. Regulatory bodies like the FDA, EMA, and other national authorities enforce strict guidelines on drug approval, manufacturing standards, and the sourcing of raw materials. These regulations ensure the quality and safety of the active ingredients used in anti-inflammatory agents, affecting the entire supply chain.

What are the technological advancements impacting the upstream activities in the Anti-inflammatory Agents Market in 2025?

Technological advancements in biotechnology and molecular engineering are impacting the upstream activities by enabling the development of more effective biologics and novel anti-inflammatory therapies. Automation in manufacturing, improvements in drug delivery systems, and advances in synthesis processes also contribute to more efficient production of anti-inflammatory agents.

What are the challenges faced by upstream suppliers in the Anti-inflammatory Agents Market in 2025?

Upstream suppliers face challenges such as fluctuating raw material costs, supply chain disruptions, and the need to comply with evolving regulatory standards. The increasing demand for biologics and personalized therapies also requires significant investment in specialized production facilities, making scalability and cost management challenging.

What are the key activities in the midstream segment of the Anti-inflammatory Agents Market in 2025?

The key activities in the midstream segment include the formulation, manufacturing, and packaging of anti-inflammatory agents. This stage also involves quality control, clinical trials for new formulations, and compliance with regulatory requirements before the products are distributed to healthcare providers and pharmacies.

What role do distributors and wholesalers play in the midstream of the Anti-inflammatory Agents Market in 2025?

Distributors and wholesalers act as intermediaries between manufacturers and healthcare providers, ensuring that anti-inflammatory agents are available in the required quantities and reach pharmacies, hospitals, and clinics. They manage logistics, inventory, and facilitate the distribution process across different regions.

What are the regulatory and quality control requirements in the midstream segment of the Anti-inflammatory Agents Market in 2025?

Regulatory and quality control requirements in this segment are critical to ensuring that products meet safety standards. Manufacturers must comply with Good Manufacturing Practices (GMP) and adhere to strict guidelines set by regulatory agencies like the FDA and EMA. These standards cover aspects such as production processes, labeling, storage, and transportation to maintain the efficacy and safety of the products.

What are the technological advancements affecting midstream operations in the Anti-inflammatory Agents Market in 2025?

Technological advancements like automated production lines, advanced packaging techniques, and real-time quality monitoring systems are enhancing efficiency and precision in the midstream segment. Additionally, innovations in drug delivery technologies, such as controlled-release formulations and biologic delivery systems, are improving the effectiveness of anti-inflammatory therapies.

What are the challenges faced by the midstream segment in the Anti-inflammatory Agents Market in 2025?

The midstream segment faces challenges related to maintaining the supply chain, including managing disruptions and ensuring the timely delivery of products. Fluctuating demand, particularly during seasonal peaks, and the need to comply with ever-evolving regulatory requirements are other key challenges. Additionally, the rising costs of manufacturing, including the production of complex biologics, can strain profit margins.

What are the key activities in the downstream segment of the Anti-inflammatory Agents Market in 2025?

The key activities in the downstream segment include the distribution of anti-inflammatory agents to healthcare providers, pharmacies, and patients. This stage involves retail sales, prescription fulfillment, patient education, and post-treatment follow-up to ensure proper medication adherence and monitor for potential side effects.

How do healthcare providers and pharmacies play a role in the downstream segment of the Anti-inflammatory Agents Market in 2025?

Healthcare providers, including doctors and specialists, prescribe anti-inflammatory agents based on patient needs, while pharmacies and drug stores fulfill these prescriptions. Pharmacists also play an essential role in advising patients on the proper use of medications and potential interactions, ensuring safe and effective treatment.

What are the marketing and promotional activities in the downstream segment of the Anti-inflammatory Agents Market in 2025?

Marketing and promotional activities in the downstream segment include targeted campaigns to raise awareness among healthcare professionals and patients. These activities often focus on educating consumers about the benefits and risks of anti-inflammatory treatments, promoting new product launches, and enhancing patient engagement through digital platforms and informational resources.

What technological advancements are impacting the downstream operations in the Anti-inflammatory Agents Market in 2025?

Technological advancements in telemedicine, digital health apps, and e-prescriptions are transforming downstream operations by increasing access to anti-inflammatory treatments and improving patient compliance. Additionally, advancements in personalized medicine and pharmacogenomics are allowing for more tailored treatment plans that enhance the effectiveness of anti-inflammatory agents for individual patients.

What challenges does the downstream segment face in the Anti-inflammatory Agents Market in 2025?

The downstream segment faces challenges like managing the growing complexity of treatments, particularly with biologics and new therapies, which require special handling and administration. Market fragmentation and pricing pressures in various regions can also create difficulties in distribution. Moreover, ensuring that patients have access to medications amidst regulatory and reimbursement hurdles remains a key challenge.

Chapter 1, to describe Anti-inflammatory Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-inflammatory Agents, with revenue, gross margin, and global market share of Anti-inflammatory Agents from 2019 to 2024.
Chapter 3, the Anti-inflammatory Agents competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Anti-inflammatory Agents market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-inflammatory Agents.
Chapter 13, to describe Anti-inflammatory Agents research findings and conclusion.

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-inflammatory Agents by Type
1.3.1 Overview: Global Anti-inflammatory Agents Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Anti-inflammatory Agents Consumption Value Market Share by Type in 2023
1.3.3 Software
1.3.4 Services
1.4 Global Anti-inflammatory Agents Market by Application
1.4.1 Overview: Global Anti-inflammatory Agents Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical and Biotechnology Companies
1.4.3 Contract Research and Development Organizations
1.4.4 Others
1.5 Global Anti-inflammatory Agents Market Size & Forecast
1.6 Global Anti-inflammatory Agents Market Size and Forecast by Region
1.6.1 Global Anti-inflammatory Agents Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Anti-inflammatory Agents Market Size by Region, (2019-2030)
1.6.3 North America Anti-inflammatory Agents Market Size and Prospect (2019-2030)
1.6.4 Europe Anti-inflammatory Agents Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Anti-inflammatory Agents Market Size and Prospect (2019-2030)
1.6.6 South America Anti-inflammatory Agents Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Anti-inflammatory Agents Market Size and Prospect (2019-2030)

2 Company Profiles

2.1 Thermo Fisher Scientific Inc
2.1.1 Thermo Fisher Scientific Inc Details
2.1.2 Thermo Fisher Scientific Inc Major Business
2.1.3 Thermo Fisher Scientific Inc Anti-inflammatory Agents Product and Solutions
2.1.4 Thermo Fisher Scientific Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.2 Oracle Corporation
2.2.1 Oracle Corporation Details
2.2.2 Oracle Corporation Major Business
2.2.3 Oracle Corporation Anti-inflammatory Agents Product and Solutions
2.2.4 Oracle Corporation Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Oracle Corporation Recent Developments and Future Plans
2.3 Revvity, Inc
2.3.1 Revvity, Inc Details
2.3.2 Revvity, Inc Major Business
2.3.3 Revvity, Inc Anti-inflammatory Agents Product and Solutions
2.3.4 Revvity, Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Revvity, Inc Recent Developments and Future Plans
2.4 Clario
2.4.1 Clario Details
2.4.2 Clario Major Business
2.4.3 Clario Anti-inflammatory Agents Product and Solutions
2.4.4 Clario Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Clario Recent Developments and Future Plans
2.5 Illumina, Inc
2.5.1 Illumina, Inc Details
2.5.2 Illumina, Inc Major Business
2.5.3 Illumina, Inc Anti-inflammatory Agents Product and Solutions
2.5.4 Illumina, Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Illumina, Inc Recent Developments and Future Plans
2.6 Qiagen NV
2.6.1 Qiagen NV Details
2.6.2 Qiagen NV Major Business
2.6.3 Qiagen NV Anti-inflammatory Agents Product and Solutions
2.6.4 Qiagen NV Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Qiagen NV Recent Developments and Future Plans
2.7 Agilent Technologies, Inc
2.7.1 Agilent Technologies, Inc Details
2.7.2 Agilent Technologies, Inc Major Business
2.7.3 Agilent Technologies, Inc Anti-inflammatory Agents Product and Solutions
2.7.4 Agilent Technologies, Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Agilent Technologies, Inc Recent Developments and Future Plans
2.8 IBM Corporation
2.8.1 IBM Corporation Details
2.8.2 IBM Corporation Major Business
2.8.3 IBM Corporation Anti-inflammatory Agents Product and Solutions
2.8.4 IBM Corporation Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 IBM Corporation Recent Developments and Future Plans
2.9 Genedata AG
2.9.1 Genedata AG Details
2.9.2 Genedata AG Major Business
2.9.3 Genedata AG Anti-inflammatory Agents Product and Solutions
2.9.4 Genedata AG Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Genedata AG Recent Developments and Future Plans
2.10 DNAnexus, Inc
2.10.1 DNAnexus, Inc Details
2.10.2 DNAnexus, Inc Major Business
2.10.3 DNAnexus, Inc Anti-inflammatory Agents Product and Solutions
2.10.4 DNAnexus, Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 DNAnexus, Inc Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Anti-inflammatory Agents Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Anti-inflammatory Agents by Company Revenue
3.2.2 Top 3 Anti-inflammatory Agents Players Market Share in 2023
3.2.3 Top 6 Anti-inflammatory Agents Players Market Share in 2023
3.3 Anti-inflammatory Agents Market: Overall Company Footprint Analysis
3.3.1 Anti-inflammatory Agents Market: Region Footprint
3.3.2 Anti-inflammatory Agents Market: Company Product Type Footprint
3.3.3 Anti-inflammatory Agents Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Anti-inflammatory Agents Consumption Value and Market Share by Type (2019-2024)
4.2 Global Anti-inflammatory Agents Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

5.1 Global Anti-inflammatory Agents Consumption Value Market Share by Application (2019-2024)
5.2 Global Anti-inflammatory Agents Market Forecast by Application (2025-2030)

6 North America

6.1 North America Anti-inflammatory Agents Consumption Value by Type (2019-2030)
6.2 North America Anti-inflammatory Agents Market Size by Application (2019-2030)
6.3 North America Anti-inflammatory Agents Market Size by Country
6.3.1 North America Anti-inflammatory Agents Consumption Value by Country (2019-2030)
6.3.2 United States Anti-inflammatory Agents Market Size and Forecast (2019-2030)
6.3.3 Canada Anti-inflammatory Agents Market Size and Forecast (2019-2030)
6.3.4 Mexico Anti-inflammatory Agents Market Size and Forecast (2019-2030)

7 Europe

7.1 Europe Anti-inflammatory Agents Consumption Value by Type (2019-2030)
7.2 Europe Anti-inflammatory Agents Consumption Value by Application (2019-2030)
7.3 Europe Anti-inflammatory Agents Market Size by Country
7.3.1 Europe Anti-inflammatory Agents Consumption Value by Country (2019-2030)
7.3.2 Germany Anti-inflammatory Agents Market Size and Forecast (2019-2030)
7.3.3 France Anti-inflammatory Agents Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Anti-inflammatory Agents Market Size and Forecast (2019-2030)
7.3.5 Russia Anti-inflammatory Agents Market Size and Forecast (2019-2030)
7.3.6 Italy Anti-inflammatory Agents Market Size and Forecast (2019-2030)

8 Asia-Pacific

8.1 Asia-Pacific Anti-inflammatory Agents Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Anti-inflammatory Agents Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Anti-inflammatory Agents Market Size by Region
8.3.1 Asia-Pacific Anti-inflammatory Agents Consumption Value by Region (2019-2030)
8.3.2 China Anti-inflammatory Agents Market Size and Forecast (2019-2030)
8.3.3 Japan Anti-inflammatory Agents Market Size and Forecast (2019-2030)
8.3.4 South Korea Anti-inflammatory Agents Market Size and Forecast (2019-2030)
8.3.5 India Anti-inflammatory Agents Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Anti-inflammatory Agents Market Size and Forecast (2019-2030)
8.3.7 Australia Anti-inflammatory Agents Market Size and Forecast (2019-2030)

9 South America

9.1 South America Anti-inflammatory Agents Consumption Value by Type (2019-2030)
9.2 South America Anti-inflammatory Agents Consumption Value by Application (2019-2030)
9.3 South America Anti-inflammatory Agents Market Size by Country
9.3.1 South America Anti-inflammatory Agents Consumption Value by Country (2019-2030)
9.3.2 Brazil Anti-inflammatory Agents Market Size and Forecast (2019-2030)
9.3.3 Argentina Anti-inflammatory Agents Market Size and Forecast (2019-2030)

10 Middle East & Africa

10.1 Middle East & Africa Anti-inflammatory Agents Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Anti-inflammatory Agents Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Anti-inflammatory Agents Market Size by Country
10.3.1 Middle East & Africa Anti-inflammatory Agents Consumption Value by Country (2019-2030)
10.3.2 Turkey Anti-inflammatory Agents Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Anti-inflammatory Agents Market Size and Forecast (2019-2030)
10.3.4 UAE Anti-inflammatory Agents Market Size and Forecast (2019-2030)

11 Market Dynamics

11.1 Anti-inflammatory Agents Market Drivers
11.2 Anti-inflammatory Agents Market Restraints
11.3 Anti-inflammatory Agents Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Anti-inflammatory Agents Industry Chain
12.2 Anti-inflammatory Agents Upstream Analysis
12.3 Anti-inflammatory Agents Midstream Analysis
12.4 Anti-inflammatory Agents Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables

Table 1. Global Anti-inflammatory Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-inflammatory Agents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Anti-inflammatory Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Anti-inflammatory Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Thermo Fisher Scientific Inc Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Inc Major Business
Table 7. Thermo Fisher Scientific Inc Anti-inflammatory Agents Product and Solutions
Table 8. Thermo Fisher Scientific Inc Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Thermo Fisher Scientific Inc Recent Developments and Future Plans
Table 10. Oracle Corporation Company Information, Head Office, and Major Competitors
Table 11. Oracle Corporation Major Business
Table 12. Oracle Corporation Anti-inflammatory Agents Product and Solutions
Table 13. Oracle Corporation Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Oracle Corporation Recent Developments and Future Plans
Table 15. Revvity, Inc Company Information, Head Office, and Major Competitors
Table 16. Revvity, Inc Major Business
Table 17. Revvity, Inc Anti-inflammatory Agents Product and Solutions
Table 18. Revvity, Inc Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Clario Company Information, Head Office, and Major Competitors
Table 20. Clario Major Business
Table 21. Clario Anti-inflammatory Agents Product and Solutions
Table 22. Clario Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. Clario Recent Developments and Future Plans
Table 24. Illumina, Inc Company Information, Head Office, and Major Competitors
Table 25. Illumina, Inc Major Business
Table 26. Illumina, Inc Anti-inflammatory Agents Product and Solutions
Table 27. Illumina, Inc Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Illumina, Inc Recent Developments and Future Plans
Table 29. Qiagen NV Company Information, Head Office, and Major Competitors
Table 30. Qiagen NV Major Business
Table 31. Qiagen NV Anti-inflammatory Agents Product and Solutions
Table 32. Qiagen NV Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. Qiagen NV Recent Developments and Future Plans
Table 34. Agilent Technologies, Inc Company Information, Head Office, and Major Competitors
Table 35. Agilent Technologies, Inc Major Business
Table 36. Agilent Technologies, Inc Anti-inflammatory Agents Product and Solutions
Table 37. Agilent Technologies, Inc Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Agilent Technologies, Inc Recent Developments and Future Plans
Table 39. IBM Corporation Company Information, Head Office, and Major Competitors
Table 40. IBM Corporation Major Business
Table 41. IBM Corporation Anti-inflammatory Agents Product and Solutions
Table 42. IBM Corporation Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. IBM Corporation Recent Developments and Future Plans
Table 44. Genedata AG Company Information, Head Office, and Major Competitors
Table 45. Genedata AG Major Business
Table 46. Genedata AG Anti-inflammatory Agents Product and Solutions
Table 47. Genedata AG Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Genedata AG Recent Developments and Future Plans
Table 49. DNAnexus, Inc Company Information, Head Office, and Major Competitors
Table 50. DNAnexus, Inc Major Business
Table 51. DNAnexus, Inc Anti-inflammatory Agents Product and Solutions
Table 52. DNAnexus, Inc Anti-inflammatory Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. DNAnexus, Inc Recent Developments and Future Plans
Table 54. Global Anti-inflammatory Agents Revenue (USD Million) by Players (2019-2024)
Table 55. Global Anti-inflammatory Agents Revenue Share by Players (2019-2024)
Table 56. Breakdown of Anti-inflammatory Agents by Company Type (Tier 1, Tier 2, and Tier 3)
Table 57. Market Position of Players in Anti-inflammatory Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 58. Head Office of Key Anti-inflammatory Agents Players
Table 59. Anti-inflammatory Agents Market: Company Product Type Footprint
Table 60. Anti-inflammatory Agents Market: Company Product Application Footprint
Table 61. Anti-inflammatory Agents New Market Entrants and Barriers to Market Entry
Table 62. Anti-inflammatory Agents Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global Anti-inflammatory Agents Consumption Value (USD Million) by Type (2019-2024)
Table 64. Global Anti-inflammatory Agents Consumption Value Share by Type (2019-2024)
Table 65. Global Anti-inflammatory Agents Consumption Value Forecast by Type (2025-2030)
Table 66. Global Anti-inflammatory Agents Consumption Value by Application (2019-2024)
Table 67. Global Anti-inflammatory Agents Consumption Value Forecast by Application (2025-2030)
Table 68. North America Anti-inflammatory Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 69. North America Anti-inflammatory Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 70. North America Anti-inflammatory Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 71. North America Anti-inflammatory Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 72. North America Anti-inflammatory Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 73. North America Anti-inflammatory Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 74. Europe Anti-inflammatory Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 75. Europe Anti-inflammatory Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 76. Europe Anti-inflammatory Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Europe Anti-inflammatory Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Europe Anti-inflammatory Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 79. Europe Anti-inflammatory Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Asia-Pacific Anti-inflammatory Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Asia-Pacific Anti-inflammatory Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Asia-Pacific Anti-inflammatory Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Asia-Pacific Anti-inflammatory Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Asia-Pacific Anti-inflammatory Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Asia-Pacific Anti-inflammatory Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 86. South America Anti-inflammatory Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 87. South America Anti-inflammatory Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 88. South America Anti-inflammatory Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 89. South America Anti-inflammatory Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 90. South America Anti-inflammatory Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Anti-inflammatory Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Anti-inflammatory Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 93. Middle East & Africa Anti-inflammatory Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 94. Middle East & Africa Anti-inflammatory Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 95. Middle East & Africa Anti-inflammatory Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 96. Middle East & Africa Anti-inflammatory Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 97. Middle East & Africa Anti-inflammatory Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Global Key Players of Anti-inflammatory Agents Upstream (Raw Materials)
Table 99. Global Anti-inflammatory Agents Typical Customers

List of Figures

Figure 1. Anti-inflammatory Agents Picture
Figure 2. Global Anti-inflammatory Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-inflammatory Agents Consumption Value Market Share by Type in 2023
Figure 4. Software
Figure 5. Services
Figure 6. Global Anti-inflammatory Agents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Anti-inflammatory Agents Consumption Value Market Share by Application in 2023
Figure 8. Pharmaceutical and Biotechnology Companies Picture
Figure 9. Contract Research and Development Organizations Picture
Figure 10. Others Picture
Figure 11. Global Anti-inflammatory Agents Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Anti-inflammatory Agents Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Anti-inflammatory Agents Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 14. Global Anti-inflammatory Agents Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Anti-inflammatory Agents Consumption Value Market Share by Region in 2023
Figure 16. North America Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East & Africa Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Anti-inflammatory Agents Revenue Share by Players in 2023
Figure 23. Anti-inflammatory Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 24. Market Share of Anti-inflammatory Agents by Player Revenue in 2023
Figure 25. Top 3 Anti-inflammatory Agents Players Market Share in 2023
Figure 26. Top 6 Anti-inflammatory Agents Players Market Share in 2023
Figure 27. Global Anti-inflammatory Agents Consumption Value Share by Type (2019-2024)
Figure 28. Global Anti-inflammatory Agents Market Share Forecast by Type (2025-2030)
Figure 29. Global Anti-inflammatory Agents Consumption Value Share by Application (2019-2024)
Figure 30. Global Anti-inflammatory Agents Market Share Forecast by Application (2025-2030)
Figure 31. North America Anti-inflammatory Agents Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Anti-inflammatory Agents Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Anti-inflammatory Agents Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Anti-inflammatory Agents Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Anti-inflammatory Agents Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Anti-inflammatory Agents Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 41. France Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Anti-inflammatory Agents Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Anti-inflammatory Agents Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Anti-inflammatory Agents Consumption Value Market Share by Region (2019-2030)
Figure 48. China Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 51. India Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Anti-inflammatory Agents Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Anti-inflammatory Agents Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Anti-inflammatory Agents Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East & Africa Anti-inflammatory Agents Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East & Africa Anti-inflammatory Agents Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East & Africa Anti-inflammatory Agents Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Anti-inflammatory Agents Consumption Value (2019-2030) & (USD Million)
Figure 65. Anti-inflammatory Agents Market Drivers
Figure 66. Anti-inflammatory Agents Market Restraints
Figure 67. Anti-inflammatory Agents Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Anti-inflammatory Agents Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source